Company: DARE
Filing Date: 2025-03-31
Form Type: 10-K
Source: 0001401914-25-000012
Chunk: 57

Company: Dare Bioscience, Inc.
Filing Date: 2025-03-31
Form: 10-K
Item: Item 8
Chunk 57
---
 Certificate of Amendment of Restated Certificate of Incorporation dated June 21, 20248-K001-3639506/27/20243.23.2Third Amended and Restated By-Laws (as amended through January 24, 2023)10-Q001-363955/14/20243.1INSTRUMENTS DEFINING RIGHTS OF SECURITY HOLDERS4.1Specimen stock certificate evidencing the shares of common stock10-K001-3639503/28/20184.1

134

4.2Warrant Agreement to purchase shares of common stock of the registrant with Aquilo Partners, L.P., entered into as of October 16, 2016. 10-K001-3639503/31/20224.24.3Form of common stock purchase warrants issued on September 1, 20238-K0001-3639508/30/20234.14.4Form of common stock purchase warrants issued on December 21, 202310-K001-3639503/28/20244.44.5Description of securities of the registrant10-K001-3639503/27/20204.6COMMERCIAL AGREEMENTS10.1(a)+Exclusive License Agreement dated March 31, 2022 between Organon International GmbH and Dare Bioscience, Inc., effective as of June 30, 202210-Q001-3639505/12/202210.110.1(b)+First Amendment to License Agreement by and between Organon International GmbH and Dare Bioscience, Inc. entered into as of July 4, 202310-Q001-3639511/09/202310.210.2+Consent, Waiver and Stand-By License Agreement, dated March 30, 2022, by and among TriLogic Pharma, LLC, and MilanaPharm LLC, Dare Bioscience, Inc., and Organon International GmbH.10-Q001-3639505/12/202210.210.3ΔLicense and Collaboration Agreement dated February 11, 2018 between Daré Bioscience, Inc., Strategic Science and Technologies-D, LLC and Strategic Science Technologies, LLC10-K/A001-3639504/30/201810.110.4ΔLicense Agreement dated March 19, 2017, between Daré Bioscience Operations, Inc. and ADVA-Tec, Inc.10-Q001-3639511/13/